Open Insider Trading Activity for Enliven Therapeutics, Inc. CHIEF FINANCIAL OFFICER Hohl Benjamin
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-09-21 | 2026-09-17 | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3 | 6,018 | $50.35 | $303,003.01 | 13.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-06-22 | 2026-06-17 | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3 | 6,018 | $43.80 | $263,575.77 | 3.65% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ELVN | 2026-03-10 | 2026-03-06 | Enliven Therapeutics, Inc. | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1 | 10,000 | $29.58 | $295,800.00 | 16.39% | View Filing |